激情综合啪啪6月丁香,久久久久国产精品91福利,99精品日韩欧美在线观看,91成人午夜福利在线观看国产

技術(shù)中心

技術(shù)文獻(xiàn):小鼠IL-1β,IL-6,等ELISA試劑盒技術(shù)文獻(xiàn)

2021年03月17日 10:54:53人氣:1054來(lái)源:上海勁馬實(shí)驗(yàn)設(shè)備有限公司

資料類型pdf文件資料大小4142329
下載次數(shù)11資料圖片 【點(diǎn)擊查看】
上 傳 人上海勁馬實(shí)驗(yàn)設(shè)備有限公司 需要積分0
關(guān) 鍵 詞技術(shù)文獻(xiàn):小鼠IL-1β,IL-6,等ELISA試劑盒技術(shù)文獻(xiàn)
【資料簡(jiǎn)介】

【文獻(xiàn)標(biāo)題】Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides
【作者】Yongjie Zhu, Changxuan Shao, Guoyu Li,et.al
【作者單位】東北農(nóng)業(yè)大學(xué)( Northeast Agricultural University)
【文獻(xiàn)中引用產(chǎn)品】
小鼠白介素1β (IL-1β)ELISA試劑盒
小鼠白介素6(IL-6)ELISA試劑盒
小鼠腫瘤壞死因子α(TNF-α)ELISA試劑盒
【DOI】dx.doi.org/10.1021/acs.jmedchem.0c00583
【影響因子(IF)】2.57
【出版期刊】《MED CHEM》
【產(chǎn)品原文引用】
In Vivo Efficacy Assay (Peritonitis-Sepsis Mode
Twenty-four C57BL/6 female mice (Liaoning Changsheng Biotechnology Co., Ltd.,Benxi, China) aged 6?7 weeks and weighing 20?22 g were randomly divided into the following three groups (n = 8): (a) control group(saline), (b) infection group (E. coli), and (c) treatment group (E. coli + II-I4-II). After 3 days of prefeeding, 100 μL of saline was injected into the peritoneal cavity of mice in the control group, while other mice received 100 μL of E. coli 25922 (~1 × 108 CFU/mL) to initiate infection. The treatment group was treated with II-I4-II (10 mg/kg) via intraperitoneal injection 1 h after infection, while the control group and infection group received saline. Then, 12 h after the infection, the mice were euthanized. At the same time, the liver, spleen, kidney, and lung of mice were taken out and weighed to analyze the bacterial load in those organs. For histopathological examination, liver, spleen, kidney, and lung sections were fixed in  4% paraformaldehyde, embedded in paraffin, and stained with hematoxylin and eosin. The level of IL-1β, IL-6, and TNF-α in the serum was analyzed with ELISA kits (Shanghai Jinma)


完整版PDF文獻(xiàn)請(qǐng)咨詢?cè)诰€客服或者聯(lián)XI我司業(yè)務(wù)員!
更多公司福利請(qǐng)關(guān)注“上海勁馬”VX公眾號(hào)!

上海勁馬實(shí)驗(yàn)設(shè)備有限公司作者

上一篇:人流感病毒A(FLU A)ELISA試劑盒實(shí)驗(yàn)檢測(cè)

下一篇:人抗肝細(xì)胞膜抗體(LMA)ELISA試劑盒技術(shù)原理


我要投稿
  • 投稿請(qǐng)發(fā)送郵件至:(郵件標(biāo)題請(qǐng)備注“投稿”)hbzhan@vip.qq.com
  • 聯(lián)系電話0571-87759680
環(huán)保行業(yè)“互聯(lián)網(wǎng)+”服務(wù)平臺(tái)
環(huán)保在線APP

功能豐富 實(shí)時(shí)交流

環(huán)保在線小程序

訂閱獲取更多服務(wù)

微信公眾號(hào)

關(guān)注我們

抖音

環(huán)保在線網(wǎng)

抖音號(hào):hbzhan

打開(kāi)抖音 搜索頁(yè)掃一掃

視頻號(hào)

環(huán)保在線

公眾號(hào):環(huán)保在線

打開(kāi)微信掃碼關(guān)注視頻號(hào)

快手

環(huán)保在線

快手ID:2537047074

打開(kāi)快手 掃一掃關(guān)注
意見(jiàn)反饋